Pulse Biosciences, Inc. (PLSE) Misses Q1 EPS by 4c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q1 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge
• Travel + Leisure (TNL) Reiterated at Buy by Stifel: 'There is Upside to the Multiple'